Ankerstar Wealth’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Ankerstar Wealth's PCRX Position: Q3 2026 in Review
Ankerstar Wealth held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 12 shares worth $301. The position accounts for ﹤0.01% of the portfolio, ranked #837.
Ankerstar Wealth first reported a position in PCRX in Q4 2025 and has held it in 4 quarters since. The position peaked at $304 in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Ankerstar Wealth held 12 shares of Pacira BioSciences worth $301 as of Q3 2026.
- Ankerstar Wealth left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up ﹤0.01% of Ankerstar Wealth's portfolio in Q3 2026, its #837 holding.
- Ankerstar Wealth first reported a position in Pacira BioSciences in Q4 2025 and has held it in 4 quarters since.
- Ankerstar Wealth's Pacira BioSciences position peaked at $304 in Q2 2026.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Ankerstar Wealth's 13F filing for Q3 2026, filed 13 Nov 2026.